Sodium-Glucose Cotransporter 2 Inhibitor [EPC]

Sodium-Glucose Cotransporter 2 Inhibitor [EPC] was reported 109123 times

These side effects are most commonly reported by patients taking drugs of the Sodium-Glucose Cotransporter 2 Inhibitor [EPC] class:

# Drug class Count
0 DEATH 6506
1 NAUSEA 5426
2 DIABETIC KETOACIDOSIS 5298
3 DIARRHOEA 5019
4 FATIGUE 4462
5 BLOOD GLUCOSE INCREASED 4409
6 OFF LABEL USE 4406
7 DIZZINESS 4291
8 VOMITING 4280
9 DYSPNOEA 4064
10 WEIGHT DECREASED 4031
11 ACUTE KIDNEY INJURY 3689
12 DRUG INEFFECTIVE 3303
13 HEADACHE 3060
14 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2909
15 URINARY TRACT INFECTION 2865
16 MALAISE 2672
17 DEHYDRATION 2649
18 ASTHENIA 2474
19 FUNGAL INFECTION 2458
20 HYPOTENSION 2405
21 PAIN 2386
22 PRURITUS 2266
23 DECREASED APPETITE 2153
24 KETOACIDOSIS 2150
25 FALL 2136
26 ARTHRALGIA 2125
27 CARDIAC FAILURE 2021
28 COVID-19 1957
29 RASH 1935
30 COUGH 1754
31 MYOCARDIAL INFARCTION 1746
32 PNEUMONIA 1739
33 ABDOMINAL PAIN UPPER 1719
34 ABDOMINAL PAIN 1717
35 PYREXIA 1708
36 ABDOMINAL DISCOMFORT 1658
37 CONSTIPATION 1634
38 BACK PAIN 1582
39 CEREBROVASCULAR ACCIDENT 1574
40 PRODUCT DOSE OMISSION ISSUE 1568
41 GLYCOSYLATED HAEMOGLOBIN INCREASED 1565
42 PAIN IN EXTREMITY 1494
43 RENAL IMPAIRMENT 1459
44 FOURNIER^S GANGRENE 1450
45 CHEST PAIN 1449
46 PERIPHERAL SWELLING 1440
47 POLLAKIURIA 1388
48 FEELING ABNORMAL 1352
49 CONDITION AGGRAVATED 1338
50 LACTIC ACIDOSIS 1316
51 METABOLIC ACIDOSIS 1314
52 INSOMNIA 1253
53 DRUG INTERACTION 1247
54 HYPERTENSION 1218
55 ATRIAL FIBRILLATION 1216
56 WEIGHT INCREASED 1207
57 PALPITATIONS 1203
58 SEPSIS 1198
59 HYPOGLYCAEMIA 1174
60 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1151
61 ANXIETY 1139
62 VISUAL IMPAIRMENT 1130
63 HYPERKALAEMIA 1108
64 RENAL FAILURE 1095
65 CONFUSIONAL STATE 1057
66 HYPERHIDROSIS 1045
67 DIABETES MELLITUS 1025
68 INTENTIONAL PRODUCT USE ISSUE 1020
69 MEMORY IMPAIRMENT 1020
70 ILLNESS 1017
71 SOMNOLENCE 1009
72 MUSCULAR WEAKNESS 997
73 HEART RATE INCREASED 937
74 BLOOD PRESSURE INCREASED 929
75 ALOPECIA 893
76 OEDEMA PERIPHERAL 892
77 PRODUCT USE IN UNAPPROVED INDICATION 886
78 ANAEMIA 884
79 DEPRESSION 880
80 INJECTION SITE PAIN 871
81 GAIT DISTURBANCE 860
82 TACHYCARDIA 856
83 BLOOD GLUCOSE DECREASED 847
84 PANCREATITIS 843
85 BLOOD CREATININE INCREASED 842
86 MYALGIA 821
87 MUSCLE SPASMS 806
88 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 802
89 CARDIAC DISORDER 797
90 PRODUCT USE ISSUE 795
91 HYPERGLYCAEMIA 794
92 INCORRECT DOSE ADMINISTERED 792
93 DRY SKIN 785
94 BLOOD GLUCOSE ABNORMAL 781
95 GENERAL PHYSICAL HEALTH DETERIORATION 779
96 MIGRAINE 769
97 IMPAIRED GASTRIC EMPTYING 765
98 LOSS OF CONSCIOUSNESS 751
99 BLINDNESS 744
100 BLOOD PRESSURE DECREASED 732
101 SYNCOPE 720
102 CHRONIC KIDNEY DISEASE 717
103 GLOMERULAR FILTRATION RATE DECREASED 710
104 NASOPHARYNGITIS 707
105 ABDOMINAL DISTENSION 705
106 DYSPEPSIA 687
107 HALLUCINATION 682
108 INTENTIONAL PRODUCT MISUSE 680
109 TINNITUS 680
110 DIABETES MELLITUS INADEQUATE CONTROL 666
111 TREMOR 666
112 INFECTION 665
113 VISION BLURRED 660
114 CARDIAC FAILURE CONGESTIVE 657
115 DYSURIA 638
116 PRURITUS GENITAL 635
117 AMNESIA 628
118 ANGIOEDEMA 624
119 VENTRICULAR TACHYCARDIA 620
120 TRANSIENT ISCHAEMIC ATTACK 613
121 ERYTHEMA 602
122 DISTURBANCE IN ATTENTION 600
123 MEDICATION ERROR 583
124 DRY MOUTH 582
125 CHEST DISCOMFORT 581
126 HYPOAESTHESIA 581
127 LIP SWELLING 568
128 HYPERSENSITIVITY 547
129 GASTROINTESTINAL DISORDER 546
130 RENAL DISORDER 543
131 COGNITIVE DISORDER 539
132 THIRST 530
133 EYE PRURITUS 523
134 INFLUENZA 518
135 ARTHRITIS 516
136 URTICARIA 516
137 PULMONARY EMBOLISM 512
138 STRESS 503
139 DIPLOPIA 490
140 HAEMATOCHEZIA 489
141 HYPONATRAEMIA 485
142 SEPTIC SHOCK 482
143 NEUROPATHY PERIPHERAL 480
144 VASCULITIS 477
145 DYSPNOEA EXERTIONAL 475
146 JOINT SWELLING 475
147 VERTIGO 467
148 HYPOACUSIS 462
149 GASTROOESOPHAGEAL REFLUX DISEASE 456
150 CATARACT 453
151 FLATULENCE 450
152 CHILLS 448
153 ADVERSE DRUG REACTION 445
154 PERICARDITIS 444
155 FLUID RETENTION 442
156 DYSPHAGIA 440
157 CARDIAC ARREST 438
158 OXYGEN SATURATION DECREASED 437
159 PAIN OF SKIN 437
160 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 436
161 SUBARACHNOID HAEMORRHAGE 436
162 HYPOKALAEMIA 434
163 EPISTAXIS 432
164 DRUG HYPERSENSITIVITY 431
165 PANCREATITIS ACUTE 431
166 MUSCLE TWITCHING 428
167 ANOSMIA 427
168 UROSEPSIS 424
169 ARRHYTHMIA 422
170 CAROTID ARTERY OCCLUSION 422
171 FACIAL PAIN 421
172 OEDEMA 420
173 HAEMATURIA 418
174 ACUTE MYOCARDIAL INFARCTION 417
175 ATRIAL TACHYCARDIA 416
176 PSORIASIS 416
177 PARAESTHESIA 410
178 THERAPY INTERRUPTED 408
179 NECROTISING FASCIITIS 407
180 OROPHARYNGEAL PAIN 407
181 CARDIOSPASM 404
182 HOSPITALISATION 403
183 TENSION HEADACHE 402
184 ASTHMA 400
185 SLEEP TERROR 399
186 PULMONARY OEDEMA 398
187 PALMOPLANTAR KERATODERMA 394
188 RHABDOMYOLYSIS 394
189 EJECTION FRACTION DECREASED 392
190 TOXICITY TO VARIOUS AGENTS 392
191 HOT FLUSH 388
192 PLATELET COUNT DECREASED 388
193 DYSGEUSIA 384
194 SWELLING 384
195 HAEMOGLOBIN DECREASED 383
196 DRUG INTOLERANCE 381
197 NEOPLASM MALIGNANT 380
198 ECZEMA 378
199 CELLULITIS 377
200 DEMENTIA 375
201 ACCIDENTAL OVERDOSE 374
202 RHINORRHOEA 374
203 BALANCE DISORDER 369
204 CANDIDA INFECTION 368
205 DEEP VEIN THROMBOSIS 368
206 THROMBOCYTOPENIA 363
207 LETHARGY 361
208 RECTAL HAEMORRHAGE 359
209 PLEURAL EFFUSION 355
210 URINARY INCONTINENCE 355
211 TYPE 2 DIABETES MELLITUS 353
212 OVERDOSE 349
213 KETOSIS 348
214 CONTUSION 344
215 RASH PAPULAR 344
216 SEIZURE 341
217 TUBULOINTERSTITIAL NEPHRITIS 338
218 URINARY RETENTION 335
219 INJECTION SITE HAEMORRHAGE 334
220 MOBILITY DECREASED 334
221 SKIN ULCER 330
222 BRADYCARDIA 329
223 NEPHROLITHIASIS 329
224 SINUSITIS 328
225 SWOLLEN TONGUE 328
226 POLYURIA 327
227 SLEEP DISORDER 323
228 HYPOPHAGIA 321
229 PRODUCTIVE COUGH 321
230 RESPIRATORY FAILURE 321
231 COLITIS ULCERATIVE 320
232 SWELLING FACE 318
233 C-REACTIVE PROTEIN INCREASED 316
234 CEREBRAL INFARCTION 315
235 FREQUENT BOWEL MOVEMENTS 313
236 NASAL CONGESTION 313
237 SKIN EXFOLIATION 311
238 ACIDOSIS 310
239 CARDIAC FAILURE CHRONIC 308
240 THROMBOSIS 303
241 CYSTITIS 297
242 CORONARY ARTERY DISEASE 292
243 VULVOVAGINAL PRURITUS 291
244 URINE KETONE BODY PRESENT 290
245 SURGERY 289
246 ABNORMAL LOSS OF WEIGHT 285
247 HEPATIC ENZYME INCREASED 283
248 BLOOD UREA INCREASED 282
249 BLOOD POTASSIUM INCREASED 281
250 GASTROINTESTINAL HAEMORRHAGE 281
251 HYPOVOLAEMIA 281
252 EYE PAIN 280
253 CHOLELITHIASIS 275
254 INJECTION SITE BRUISING 273
255 BRONCHITIS 271
256 ANGINA PECTORIS 270
257 BLOOD GLUCOSE FLUCTUATION 270
258 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 270
259 EXTRA DOSE ADMINISTERED 267
260 MUSCULOSKELETAL STIFFNESS 267
261 NIGHTMARE 266
262 ALTERED STATE OF CONSCIOUSNESS 263
263 BLOOD CHOLESTEROL INCREASED 263
264 NEUTROPENIA 263
265 INTESTINAL OBSTRUCTION 262
266 PROTEINURIA 262
267 HEART RATE DECREASED 260
268 DISCOMFORT 257
269 IMMUNISATION 257
270 HAEMORRHAGE 256
271 DYSPHONIA 255
272 WHEEZING 255
273 LIMB INJURY 251
274 ERUCTATION 250
275 BRONCHIECTASIS 248
276 ALANINE AMINOTRANSFERASE INCREASED 245
277 FLUSHING 245
278 RHEUMATOID ARTHRITIS 245
279 THERAPY CESSATION 243
280 TREATMENT NONCOMPLIANCE 243
281 BLOOD POTASSIUM DECREASED 242
282 SUICIDAL IDEATION 241
283 BLOOD KETONE BODY INCREASED 240
284 UNDERDOSE 239
285 SYSTEMIC LUPUS ERYTHEMATOSUS 235
286 MITRAL VALVE INCOMPETENCE 234
287 THROAT IRRITATION 234
288 BURNING SENSATION 233
289 DISEASE PROGRESSION 232
290 PRESYNCOPE 231
291 OSTEOARTHRITIS 230
292 THERAPEUTIC RESPONSE UNEXPECTED 230
293 IMPAIRED QUALITY OF LIFE 229
294 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 229
295 INJECTION SITE ERYTHEMA 227
296 LUNG DISORDER 225
297 TOE AMPUTATION 225
298 MICTURITION URGENCY 224
299 POLYCYTHAEMIA 223
300 DEAFNESS 222
301 RASH PRURITIC 222
302 BLISTER 219
303 GAIT INABILITY 219
304 DEPRESSED MOOD 218
305 CARDIAC MURMUR 217
306 ORTHOSTATIC HYPOTENSION 217
307 WHITE BLOOD CELL COUNT DECREASED 217
308 DEVICE ISSUE 216
309 INTERSTITIAL LUNG DISEASE 216
310 INFLAMMATION 214
311 MULTIPLE ORGAN DYSFUNCTION SYNDROME 213
312 SHOCK 212
313 VULVOVAGINAL MYCOTIC INFECTION 211
314 LOCALISED INFECTION 210
315 IMPAIRED WORK ABILITY 209
316 NECK PAIN 209
317 PYELONEPHRITIS 209
318 BLOOD TRIGLYCERIDES INCREASED 207
319 MELAENA 207
320 SPEECH DISORDER 207
321 BALANOPOSTHITIS 205
322 BLOOD PRESSURE SYSTOLIC INCREASED 204
323 DRUG-INDUCED LIVER INJURY 204
324 PAROSMIA 204
325 PRODUCT PRESCRIBING ERROR 203
326 THERAPY NON-RESPONDER 203
327 ANAPHYLACTIC REACTION 202
328 NO ADVERSE EVENT 202
329 DELIRIUM 201
330 GINGIVAL PAIN 201
331 FEELING HOT 199
332 HEPATIC STEATOSIS 199
333 COMA 198
334 CONTRAINDICATED PRODUCT ADMINISTERED 198
335 DIZZINESS POSTURAL 198
336 GASTROENTERITIS 198
337 INFLUENZA LIKE ILLNESS 197
338 GASTROINTESTINAL HYPOMOTILITY 196
339 RHINITIS 196
340 BLOOD PRESSURE ABNORMAL 195
341 DEPRESSED LEVEL OF CONSCIOUSNESS 195
342 INJECTION SITE PRURITUS 194
343 HERPES ZOSTER 193
344 GLUCOSE URINE PRESENT 191
345 HYPOXIA 191
346 INJECTION SITE MASS 191
347 LEFT VENTRICULAR DYSFUNCTION 191
348 KETONURIA 189
349 MALIGNANT NEOPLASM PROGRESSION 189
350 LOWER RESPIRATORY TRACT INFECTION 188
351 WHITE BLOOD CELL COUNT INCREASED 188
352 CARDIAC FAILURE ACUTE 187
353 ILL-DEFINED DISORDER 187
354 LIVER DISORDER 186
355 PULMONARY HYPERTENSION 186
356 ISCHAEMIC STROKE 185
357 HYPOPNOEA 183
358 PANCREATIC CARCINOMA 183
359 DISORIENTATION 182
360 BLOOD URINE PRESENT 181
361 BURNS SECOND DEGREE 180
362 CATARRH 179
363 GANGRENE 179
364 LIMB DISCOMFORT 179
365 HEAD INJURY 178
366 ERECTILE DYSFUNCTION 177
367 EYE SWELLING 177
368 HAEMOGLOBIN INCREASED 177
369 HYPERTHYROIDISM 177
370 NOCTURIA 177
371 PANCYTOPENIA 177
372 CARDIAC OPERATION 176
373 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 176
374 NERVOUSNESS 176
375 BLOOD PRESSURE FLUCTUATION 174
376 GASTRITIS 173
377 HEPATIC FUNCTION ABNORMAL 173
378 EYE IRRITATION 172
379 HIP FRACTURE 172
380 STEROID DEPENDENCE 172
381 TACHYPNOEA 172
382 CARDIOMYOPATHY 170
383 DEVICE LEAKAGE 170
384 TASTE DISORDER 170
385 CARDIOGENIC SHOCK 169
386 ACUTE RESPIRATORY FAILURE 168
387 FEEDING DISORDER 168
388 GOUT 167
389 OSTEOMYELITIS 167
390 PNEUMONIA ASPIRATION 167
391 RENAL PAIN 167
392 HYPERNATRAEMIA 166
393 CEREBRAL HAEMORRHAGE 165
394 HYPOTHYROIDISM 165
395 UPPER RESPIRATORY TRACT INFECTION 165
396 FEBRILE NEUTROPENIA 164
397 SKIN DISCOLOURATION 164
398 SKIN DISORDER 164
399 DEVICE MALFUNCTION 163
400 DISEASE RECURRENCE 162
401 INTENTIONAL DOSE OMISSION 162
402 PEMPHIGOID 161
403 BREAST CANCER 160
404 COLITIS 160
405 ROAD TRAFFIC ACCIDENT 160
406 HEPATIC CYTOLYSIS 159
407 SEASONAL ALLERGY 159
408 SLEEP APNOEA SYNDROME 159
409 ELECTROLYTE IMBALANCE 158
410 INJECTION SITE SWELLING 158
411 PRODUCT STORAGE ERROR 158
412 HEART RATE IRREGULAR 157
413 ASPARTATE AMINOTRANSFERASE INCREASED 156
414 HYPERVOLAEMIA 156
415 DRY EYE 155
416 GLYCOSYLATED HAEMOGLOBIN DECREASED 155
417 HEPATIC CIRRHOSIS 155
418 INTENTIONAL OVERDOSE 155
419 WOUND 154
420 KIDNEY INFECTION 152
421 RASH ERYTHEMATOUS 152
422 LIVER INJURY 151
423 BLADDER CANCER 150
424 BONE PAIN 150
425 PRODUCT QUALITY ISSUE 150
426 AGRANULOCYTOSIS 148
427 ARTHROPATHY 148
428 BLOOD CREATINE PHOSPHOKINASE INCREASED 148
429 DIABETIC METABOLIC DECOMPENSATION 148
430 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 147
431 BLOOD SODIUM DECREASED 146
432 HYPOMAGNESAEMIA 146
433 INFUSION SITE PAIN 146
434 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 146
435 PERICARDIAL EFFUSION 146
436 CHOLECYSTITIS 145
437 LEUKOCYTOSIS 145
438 OBESITY 145
439 PRODUCT DOSE OMISSION IN ERROR 144
440 HYPOCALCAEMIA 143
441 OCULAR HYPERAEMIA 141
442 PHIMOSIS 141
443 ILEUS 140
444 INCREASED APPETITE 140
445 RASH MACULAR 140
446 DIVERTICULITIS 139
447 GENITAL INFECTION FUNGAL 138
448 POLYDIPSIA 138
449 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 138
450 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 137
451 DYSSTASIA 137
452 HUNGER 137
453 PROSTATE CANCER 137
454 PSORIATIC ARTHROPATHY 137
455 AGEUSIA 136
456 BRAIN FOG 135
457 DIABETIC FOOT 135
458 INFUSION RELATED REACTION 135
459 UNEVALUABLE EVENT 135
460 FEELING COLD 134
461 COVID-19 PNEUMONIA 133
462 EATING DISORDER 133
463 ELECTROCARDIOGRAM QT PROLONGED 133
464 COLD SWEAT 132
465 EYE DISORDER 132
466 HAEMOPTYSIS 132
467 HEPATITIS 132
468 DYSARTHRIA 131
469 ADVERSE EVENT 130
470 TROPONIN INCREASED 130
471 CHROMATURIA 129
472 JOINT INJURY 129
473 APHASIA 127
474 HAEMATOMA 127
475 RENAL TUBULAR NECROSIS 127
476 PRODUCT DOSE OMISSION 126
477 RASH MACULO-PAPULAR 126
478 ANAL INCONTINENCE 125
479 CORONARY ARTERY OCCLUSION 125
480 VIRAL INFECTION 125
481 GLYCOSURIA 124
482 PNEUMONITIS 124
483 RED BLOOD CELL COUNT DECREASED 124
484 TRICUSPID VALVE INCOMPETENCE 124
485 AGITATION 123
486 NIGHT SWEATS 123
487 ADRENAL INSUFFICIENCY 122
488 ALCOHOL POISONING 122
489 CIRCULATORY COLLAPSE 122
490 MALNUTRITION 122
491 MUSCLE ATROPHY 122
492 STOMATITIS 122
493 VENTRICULAR EXTRASYSTOLES 122
494 CARDIOMEGALY 121
495 CARDIOVASCULAR DISORDER 121
496 PALLOR 121
497 PULMONARY CONGESTION 121
498 RETCHING 121
499 HYPERLIPIDAEMIA 120
500 MOVEMENT DISORDER 120
501 POOR QUALITY SLEEP 120
502 URINE ABNORMALITY 120
503 URINE ODOUR ABNORMAL 120
504 ARTERIOSCLEROSIS 119
505 EMOTIONAL DISTRESS 119
506 IMPAIRED HEALING 119
507 LACRIMATION INCREASED 119
508 POST PROCEDURAL COMPLICATION 119
509 ACNE 118
510 SYSTEMIC CANDIDA 118
511 ABDOMINAL PAIN LOWER 117
512 CROHN^S DISEASE 117
513 JAUNDICE 117
514 LABORATORY TEST ABNORMAL 117
515 DRUG ERUPTION 116
516 HAEMATEMESIS 116
517 HYPERSOMNIA 116
518 RIB FRACTURE 116
519 VENTRICULAR FIBRILLATION 116
520 ATRIOVENTRICULAR BLOCK 115
521 GLOMERULAR FILTRATION RATE ABNORMAL 115
522 HYPOGLYCAEMIC COMA 115
523 VAGINAL HAEMORRHAGE 115
524 CHOLESTASIS 114
525 GASTRIC ULCER 114
526 HAEMORRHOIDS 114
527 OSTEOPOROSIS 114
528 PRESCRIBED UNDERDOSE 114
529 ANAL ABSCESS 112
530 BLOOD LACTIC ACID INCREASED 112
531 DIABETIC NEUROPATHY 112
532 FAECES DISCOLOURED 112
533 PAIN IN JAW 112
534 STAPHYLOCOCCAL INFECTION 112
535 RENAL INJURY 111
536 RESPIRATORY TRACT INFECTION 111
537 BACTERIAL INFECTION 110
538 BLOOD IRON DECREASED 110
539 GLAUCOMA 110
540 IRON DEFICIENCY ANAEMIA 110
541 LUNG NEOPLASM MALIGNANT 110
542 DIABETIC KETOSIS 109
543 IRRITABILITY 109
544 LIVER FUNCTION TEST ABNORMAL 109
545 SCIATICA 109
546 UNRESPONSIVE TO STIMULI 109
547 INCONTINENCE 108
548 THERAPEUTIC RESPONSE DECREASED 108
549 ACCIDENTAL UNDERDOSE 107
550 WEIGHT FLUCTUATION 107
551 THERAPEUTIC RESPONSE SHORTENED 106
552 UPPER GASTROINTESTINAL HAEMORRHAGE 106
553 DIABETIC RETINOPATHY 105
554 PERIPHERAL COLDNESS 105
555 PRODUCT ADMINISTRATION ERROR 105
556 SKIN LESION 105
557 SUICIDE ATTEMPT 105
558 TREATMENT FAILURE 105
559 HAEMATOCRIT INCREASED 104
560 PRODUCT PRESCRIBING ISSUE 104
561 EOSINOPHILIA 103
562 GAMMA-GLUTAMYLTRANSFERASE INCREASED 103
563 HYPOVOLAEMIC SHOCK 103
564 INCORRECT DOSE ADMINISTERED BY DEVICE 103
565 LYMPHADENOPATHY 103
566 LEG AMPUTATION 102
567 MENTAL DISORDER 102
568 NEURALGIA 102
569 ACUTE RESPIRATORY DISTRESS SYNDROME 101
570 ANAPHYLACTIC SHOCK 101
571 GASTROENTERITIS VIRAL 101
572 PARKINSON^S DISEASE 101
573 ACCIDENTAL EXPOSURE TO PRODUCT 100
574 FEMUR FRACTURE 100
575 GENERALISED OEDEMA 100
576 LIPASE INCREASED 100
577 MUSCULOSKELETAL PAIN 100
578 NEEDLE ISSUE 100
579 PRODUCT DISPENSING ERROR 100
580 PULMONARY MASS 100
581 RESPIRATORY DISORDER 100
582 UPPER LIMB FRACTURE 100
583 GENITAL INFECTION 99
584 THERAPEUTIC PRODUCT EFFECT DECREASED 99
585 HAEMATOCRIT DECREASED 98
586 PRODUCT SUBSTITUTION ISSUE 98
587 AGGRESSION 97
588 FULL BLOOD COUNT ABNORMAL 97
589 INABILITY TO AFFORD MEDICATION 97
590 MUSCULOSKELETAL DISCOMFORT 97
591 PROSTATITIS 97
592 COLON CANCER 96
593 LIVER FUNCTION TEST INCREASED 96
594 BLOOD CREATINE INCREASED 95
595 BLOOD ALKALINE PHOSPHATASE INCREASED 94
596 THROAT TIGHTNESS 94
597 DERMATITIS ALLERGIC 93
598 DYSKINESIA 93
599 KNEE ARTHROPLASTY 93
600 MENTAL STATUS CHANGES 93
601 SKIN IRRITATION 93
602 ABSCESS 92
603 ANURIA 92
604 BLOOD PRESSURE DIASTOLIC DECREASED 92
605 DEMENTIA ALZHEIMER^S TYPE 92
606 DUODENAL ULCER 92
607 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 92
608 MOOD ALTERED 92
609 DRUG LEVEL INCREASED 91
610 HYPOKINESIA 91
611 ORAL CANDIDIASIS 91
612 SINUS DISORDER 91
613 ASCITES 90
614 CARDIO-RESPIRATORY ARREST 90
615 CONCOMITANT DISEASE AGGRAVATED 90
616 PANIC ATTACK 90
617 SNEEZING 90
618 ATRIAL FLUTTER 89
619 BLOOD BILIRUBIN INCREASED 89
620 BLOOD MAGNESIUM DECREASED 89
621 GASTRIC DISORDER 89
622 DRUG ABUSE 88
623 FLANK PAIN 87
624 HYDRONEPHROSIS 87
625 MATERNAL EXPOSURE DURING PREGNANCY 87
626 MYOCARDIAL ISCHAEMIA 87
627 PROCEDURAL PAIN 87
628 PROTEIN URINE PRESENT 87
629 RESTLESSNESS 87
630 BACK DISORDER 86
631 DERMATITIS ATOPIC 86
632 HERNIA 86
633 INSURANCE ISSUE 86
634 LOWER LIMB FRACTURE 86
635 PANCREATITIS NECROTISING 86
636 PRODUCT AVAILABILITY ISSUE 86
637 RED CELL DISTRIBUTION WIDTH INCREASED 86
638 SKIN FISSURES 86
639 ULCER 86
640 ARTERIOSCLEROSIS CORONARY ARTERY 85
641 ATRIOVENTRICULAR BLOCK COMPLETE 84
642 BLOOD URIC ACID INCREASED 84
643 DYSLIPIDAEMIA 84
644 HEPATIC FAILURE 84
645 CARDIAC AMYLOIDOSIS 83
646 DIASTOLIC DYSFUNCTION 83
647 HALLUCINATION, VISUAL 83
648 NEUTROPHIL COUNT DECREASED 83
649 OLIGURIA 83
650 PSYCHOTIC DISORDER 83
651 VAGINAL INFECTION 83
652 VULVOVAGINAL DISCOMFORT 83
653 DEVICE DIFFICULT TO USE 82
654 GLOMERULAR FILTRATION RATE INCREASED 82
655 INJURY 82
656 ORAL PAIN 82
657 ORCHITIS 82
658 BACTERAEMIA 81
659 BLINDNESS UNILATERAL 81
660 FIBROMYALGIA 81
661 INFUSION SITE ERYTHEMA 81
662 NEPHRITIS 81
663 PRODUCT MONITORING ERROR 81
664 SUBDURAL HAEMATOMA 81
665 TOOTHACHE 81
666 DISABILITY 80
667 FEELING JITTERY 80
668 GROIN PAIN 80
669 INCORRECT PRODUCT ADMINISTRATION DURATION 80
670 NEPHROTIC SYNDROME 80
671 URINE OUTPUT INCREASED 80
672 DRUG DOSE OMISSION 79
673 DRUG DOSE OMISSION BY DEVICE 79
674 MARASMUS 79
675 MUSCLE TIGHTNESS 79
676 SPINAL OPERATION 79
677 SPINAL PAIN 79
678 TENDONITIS 79
679 APHONIA 78
680 CYST 78
681 INTERVERTEBRAL DISC PROTRUSION 78
682 RENAL CYST 78
683 SKIN BURNING SENSATION 78
684 DERMATITIS BULLOUS 77
685 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 77
686 MUSCULOSKELETAL CHEST PAIN 77
687 PLASMA CELL MYELOMA 77
688 PULMONARY ARTERIAL HYPERTENSION 77
689 RESPIRATORY TRACT CONGESTION 77
690 SKIN LACERATION 77
691 URINE OUTPUT DECREASED 77
692 VULVOVAGINAL CANDIDIASIS 77
693 CUTANEOUS VASCULITIS 76
694 FOOT FRACTURE 76
695 GENITAL SWELLING 76
696 HYPERCALCAEMIA 76
697 LOW DENSITY LIPOPROTEIN INCREASED 76
698 MENTAL IMPAIRMENT 76
699 ACUTE CORONARY SYNDROME 75
700 ARTERIAL OCCLUSIVE DISEASE 75
701 GENITAL RASH 75
702 ORTHOPNOEA 75
703 PRERENAL FAILURE 75
704 CARPAL TUNNEL SYNDROME 74
705 CORONARY ARTERY STENOSIS 74
706 CYTOKINE RELEASE SYNDROME 74
707 DILATED CARDIOMYOPATHY 74
708 FRACTURE 74
709 JOINT STIFFNESS 74
710 PERIPHERAL ISCHAEMIA 74
711 PRODUCT USE COMPLAINT 74
712 SMALL INTESTINAL OBSTRUCTION 74
713 BRASH SYNDROME 73
714 POLYNEUROPATHY 73
715 ANKLE FRACTURE 72
716 BLOOD CREATININE ABNORMAL 72
717 BLOOD PRESSURE SYSTOLIC DECREASED 72
718 EAR INFECTION 72
719 PROSTATIC SPECIFIC ANTIGEN INCREASED 72
720 SKIN HAEMORRHAGE 72
721 BENIGN PROSTATIC HYPERPLASIA 71
722 COMPLETED SUICIDE 71
723 DECREASED ACTIVITY 71
724 ESCHERICHIA INFECTION 71
725 FOETAL EXPOSURE DURING PREGNANCY 71
726 LEUKOPENIA 71
727 RALES 71
728 RESPIRATORY DISTRESS 71
729 RESPIRATORY RATE INCREASED 71
730 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 71
731 VENTRICULAR HYPOKINESIA 71
732 VITAMIN D DEFICIENCY 71
733 ANION GAP INCREASED 70
734 BODY TEMPERATURE INCREASED 70
735 CHOKING 70
736 ENCEPHALOPATHY 70
737 EXPIRED PRODUCT ADMINISTERED 70
738 MIDDLE INSOMNIA 70
739 NERVOUS SYSTEM DISORDER 70
740 OCULAR DISCOMFORT 70
741 ROTATOR CUFF SYNDROME 70
742 SPINAL FRACTURE 70
743 CLOSTRIDIUM DIFFICILE INFECTION 69
744 GENITAL PAIN 69
745 MYOCARDITIS 69
746 NEPHROPATHY 69
747 ANGINA UNSTABLE 68
748 BASAL CELL CARCINOMA 68
749 BLOOD ALBUMIN DECREASED 68
750 LEFT VENTRICULAR HYPERTROPHY 68
751 MOOD SWINGS 68
752 OROPHARYNGEAL DISCOMFORT 68
753 URINARY TRACT DISORDER 68
754 URINE PROTEIN/CREATININE RATIO INCREASED 68
755 BLOOD THYROID STIMULATING HORMONE INCREASED 67
756 DECUBITUS ULCER 67
757 DEVICE DELIVERY SYSTEM ISSUE 67
758 DRUG EFFECT LESS THAN EXPECTED 67
759 EPILEPSY 67
760 HAEMOGLOBIN ABNORMAL 67
761 HIATUS HERNIA 67
762 HYPERURICAEMIA 67
763 INJECTION SITE REACTION 67
764 PNEUMOTHORAX 67
765 SHOCK HAEMORRHAGIC 67
766 ACETONAEMIA 66
767 CORONARY ARTERY BYPASS 66
768 DRUG DEPENDENCE 66
769 GASTROINTESTINAL PAIN 66
770 HYPERLACTACIDAEMIA 66
771 PARKINSONISM 66
772 PRODUCT ADMINISTRATION INTERRUPTED 66
773 PYELONEPHRITIS ACUTE 66
774 SARS-COV-2 TEST POSITIVE 66
775 BLADDER DISORDER 65
776 BLOOD KETONE BODY 65
777 CARDIAC DYSFUNCTION 65
778 DIABETIC COMA 65
779 HYPERVENTILATION 65
780 MACULAR DEGENERATION 65
781 SCROTAL ABSCESS 65
782 TRANSAMINASES INCREASED 65
783 ELECTROCARDIOGRAM ABNORMAL 64
784 HEMIPARESIS 64
785 HICCUPS 64
786 IMMUNE-MEDIATED MYOSITIS 64
787 RENAL CANCER 64
788 ANGER 63
789 APATHY 63
790 BRAIN INJURY 63
791 CARDIAC FLUTTER 63
792 CARDIAC PACEMAKER INSERTION 63
793 DRY THROAT 63
794 GALLBLADDER DISORDER 63
795 INFARCTION 63
796 NECROSIS 63
797 PROSTATOMEGALY 63
798 PULMONARY FIBROSIS 63
799 THERAPY CHANGE 63
800 THERAPY PARTIAL RESPONDER 63
801 VISUAL ACUITY REDUCED 63
802 VULVOVAGINAL BURNING SENSATION 63
803 ABSCESS LIMB 62
804 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 62
805 BLOOD IMMUNOGLOBULIN E INCREASED 62
806 EXTREMITY NECROSIS 62
807 FLUID INTAKE REDUCED 62
808 MYOPATHY 62
809 PARAESTHESIA ORAL 62
810 PHOTOPHOBIA 62
811 RED BLOOD CELL COUNT INCREASED 62
812 SINUS TACHYCARDIA 62
813 ASPIRATION 61
814 EMPHYSEMA 61
815 END STAGE RENAL DISEASE 61
816 HEAD DISCOMFORT 61
817 INFLAMMATORY MARKER INCREASED 61
818 INSULIN RESISTANCE 61
819 LEFT ATRIAL DILATATION 61
820 LYMPHOCYTE COUNT DECREASED 61
821 NERVE COMPRESSION 61
822 THYROID DISORDER 61
823 BEDRIDDEN 60
824 CHOLECYSTECTOMY 60
825 DERMATITIS 60
826 HAEMODYNAMIC INSTABILITY 60
827 INJECTION SITE RASH 60
828 INTERNATIONAL NORMALISED RATIO INCREASED 60
829 TOXIC SKIN ERUPTION 60
830 VULVOVAGINAL PAIN 60
831 BRAIN NATRIURETIC PEPTIDE INCREASED 59
832 FOOT AMPUTATION 59
833 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 59
834 JOINT EFFUSION 59
835 OBSTRUCTIVE SLEEP APNOEA SYNDROME 59
836 PERINEAL INFECTION 59
837 RESPIRATORY ACIDOSIS 59
838 TOOTH DISORDER 59
839 BLOOD TEST ABNORMAL 58
840 CAROTID ARTERIOSCLEROSIS 58
841 DERMATITIS CONTACT 58
842 ENERGY INCREASED 58
843 HYPERTENSIVE CRISIS 58
844 HYPERTRIGLYCERIDAEMIA 58
845 MALIGNANT MEDIASTINAL NEOPLASM 58
846 PERINEAL PAIN 58
847 PRODUCT PHYSICAL ISSUE 58
848 RENAL FUNCTION TEST ABNORMAL 58
849 SPUTUM DISCOLOURED 58
850 STAPHYLOCOCCAL BACTERAEMIA 58
851 TENDERNESS 58
852 URINARY TRACT CANDIDIASIS 58
853 ABNORMAL DREAMS 57
854 AORTIC STENOSIS 57
855 CHOLECYSTITIS ACUTE 57
856 HYPOPHOSPHATAEMIA 57
857 IRON DEFICIENCY 57
858 LEFT VENTRICULAR FAILURE 57
859 OESOPHAGITIS 57
860 OVERWEIGHT 57
861 PERINEAL ABSCESS 57
862 PNEUMONIA BACTERIAL 57
863 POOR VENOUS ACCESS 57
864 RESTLESS LEGS SYNDROME 57
865 SLUGGISHNESS 57
866 ASPHYXIA 56
867 BOWEL MOVEMENT IRREGULARITY 56
868 DEVICE MECHANICAL ISSUE 56
869 FACIAL PARALYSIS 56
870 MUCOSAL INFLAMMATION 56
871 MULTIPLE SCLEROSIS 56
872 PHARYNGEAL SWELLING 56
873 RETINAL DETACHMENT 56
874 SINUS CONGESTION 56
875 TESTICULAR PAIN 56
876 THROAT CLEARING 56
877 TYPE 1 DIABETES MELLITUS 56
878 BLOOD BICARBONATE DECREASED 55
879 BLOOD CALCIUM INCREASED 55
880 CORONAVIRUS INFECTION 55
881 EXERCISE TOLERANCE DECREASED 55
882 EYE HAEMORRHAGE 55
883 FUNGAL SKIN INFECTION 55
884 GLUCOSE TOLERANCE IMPAIRED 55
885 MOUTH ULCERATION 55
886 MYELOSUPPRESSION 55
887 PLATELET COUNT INCREASED 55
888 RESPIRATORY ARREST 55
889 URINE KETONE BODY 55
890 VITAMIN B12 DEFICIENCY 55
891 BACK INJURY 54
892 HEART FAILURE WITH REDUCED EJECTION FRACTION 54
893 IMMUNE THROMBOCYTOPENIA 54
894 MICROALBUMINURIA 54
895 PHYSICAL DECONDITIONING 54
896 SCAR 54
897 SCRATCH 54
898 SKIN CANCER 54
899 TORSADE DE POINTES 54
900 AORTIC VALVE INCOMPETENCE 53
901 CONCUSSION 53
902 ERYSIPELAS 53
903 FEAR 53
904 IRRITABLE BOWEL SYNDROME 53
905 ISCHAEMIC CARDIOMYOPATHY 53
906 NERVE INJURY 53
907 PENILE SWELLING 53
908 POST PROCEDURAL INFECTION 53
909 SENSORY DISTURBANCE 53
910 URINE ALBUMIN/CREATININE RATIO INCREASED 53
911 VITAMIN B12 DECREASED 53
912 ACCIDENT 52
913 AMPUTATION 52
914 APPETITE DISORDER 52
915 DIABETIC NEPHROPATHY 52
916 EYE INFECTION 52
917 GROIN ABSCESS 52
918 INJECTION SITE WARMTH 52
919 MYASTHENIA GRAVIS 52
920 PANCREATIC DISORDER 52
921 PRODUCT RESIDUE PRESENT 52
922 SECRETION DISCHARGE 52
923 STENT PLACEMENT 52
924 AUTOIMMUNE HEPATITIS 51
925 CYANOSIS 51
926 EAR PAIN 51
927 GASTROINTESTINAL INFECTION 51
928 HEPATOTOXICITY 51
929 INFUSION SITE SWELLING 51
930 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 51
931 OPTIC ISCHAEMIC NEUROPATHY 51
932 QUALITY OF LIFE DECREASED 51
933 URINARY TRACT INFECTION FUNGAL 51
934 BALANITIS CANDIDA 50
935 DEVICE OCCLUSION 50
936 DIALYSIS 50
937 FACE OEDEMA 50
938 HIP ARTHROPLASTY 50
939 INJECTION SITE URTICARIA 50
940 METASTASES TO LIVER 50
941 MYOSITIS 50
942 PARALYSIS 50
943 PRODUCT ODOUR ABNORMAL 50
944 RIGHT VENTRICULAR FAILURE 50
945 ESCHERICHIA URINARY TRACT INFECTION 49
946 FEMORAL NECK FRACTURE 49
947 FOOD CRAVING 49
948 GENITAL ERYTHEMA 49
949 HAEMOLYTIC ANAEMIA 49
950 HYPERBILIRUBINAEMIA 49
951 NEAR DEATH EXPERIENCE 49
952 ONYCHOCLASIS 49
953 SKIN ABRASION 49
954 THYROID MASS 49
955 URINARY TRACT INFECTION BACTERIAL 49
956 ACUTE HEPATIC FAILURE 48
957 ANXIETY DISORDER 48
958 DEVICE RELATED INFECTION 48
959 EMPHYSEMATOUS PYELONEPHRITIS 48
960 FOOD POISONING 48
961 GASTRIC CANCER 48
962 GENITAL BURNING SENSATION 48
963 HYPOAESTHESIA ORAL 48
964 IDIOPATHIC PULMONARY FIBROSIS 48
965 INITIAL INSOMNIA 48
966 INTERNAL HAEMORRHAGE 48
967 MULTIPLE ALLERGIES 48
968 SUPRAVENTRICULAR TACHYCARDIA 48
969 SYNOVITIS 48
970 THINKING ABNORMAL 48
971 WRONG PRODUCT ADMINISTERED 48
972 APPENDICITIS 47
973 CHOLANGITIS 47
974 DEVICE FAILURE 47
975 DEVICE USE ERROR 47
976 EPIDIDYMITIS 47
977 FAECES SOFT 47
978 GENITAL DISCOMFORT 47
979 GYNAECOMASTIA 47
980 HYPOTHERMIA 47
981 KNEE OPERATION 47
982 ORAL DISCOMFORT 47
983 PELVIC PAIN 47
984 SINUS BRADYCARDIA 47
985 VAGINAL DISCHARGE 47
986 ABNORMAL FAECES 46
987 BODY TEMPERATURE DECREASED 46
988 CARDIAC VENTRICULAR THROMBOSIS 46
989 CLOSTRIDIUM DIFFICILE COLITIS 46
990 LARGE INTESTINE POLYP 46
991 PELVIC FRACTURE 46
992 PENILE PAIN 46
993 PROCTALGIA 46
994 TOOTH LOSS 46
995 WOUND INFECTION 46
996 ABNORMAL BEHAVIOUR 45
997 ANHEDONIA 45
998 AORTIC ARTERIOSCLEROSIS 45
999 BODY MASS INDEX INCREASED 45